Just After Pfizer's RSV Vaccine Approval For Younger Adults, GSK Layouts Encouraging Preliminary Data Showing Potential For Use In Larger Population
GSK unveils new Arexvy data showing strong protection in adults 18-49 at risk for RSV. The vaccine could broaden coverage for ...
Keep baby out of ER with RSV vaccine
Starting Nov. 4, babies born in 2024 can get Beyfortus — also known as nirsevimab — to protect against severe illness from ...
BioSpace2h
CDC Reaffirm RSV Vaccination Guidelines, Declines Expanding Coverage to Younger Adults
The CDC’s vaccine advisors on Thursday maintained that respiratory syncytial virus immunization is only recommended for ...
WGNO-TV New Orleans on MSN4h
Vaccine against flu, COVID, and RSV
The Centers for Disease Control and Prevention and the New Orleans Health Department encourage residents to vaccine against ...
psychiatryadvisor.com3h
RSV Vaccine Is Recommended for Long-Term Care Facility Residents
The RSV vaccine is unequivocally recommended for adults who are residents in skilled nursing and assisted living facilities.
BioPharma Dive25m
Sanofi earnings boosted by Beyfortus, earlier vaccine sales
Sanofi and partner AstraZeneca recently increased production capacity for their RSV antibody shot, sales of which jumped ...
Fresh plea for Londoners to get vaccinated against Covid, flu and RSV ahead of winter surge
Health officials on Friday issued a fresh plea for Londoners to get vaccinated ahead of an expected surge of flu, Covid and ...
Pharmabiz8h
New data for Arexvy, GSK’s RSV vaccine, show potential to help protect a broader group of adults at increased risk for RSV disease
New data for Arexvy, GSK’s RSV vaccine, show potential to help protect a broader group of adults at increased risk for RSV disease: London, UK Friday, October 25, 2024, 13:00 Hr ...
FiercePharma1h
Sanofi shrugs off potential RSV competition from Merck as Beyfortus grows sales 382%
On a Friday call with analysts, Sanofi execs pointed to an efficacy edge for its preventive and stressed that more ...
Symptoms of respiratory illness soaring as rates in hospital double in a week
The UK Health Security Agency has said increasing numbers of infants under one year old are being seen in hospital emergency ...
Brutal tripledemic warning as experts fear millions aren't doing one thing
Health officials are concerned millions of people with health issues aren't taking up vaccination offers as UK faces a triple ...
Monthly Prescribing Reference18h
Arexvy Looks Promising for RSV Protection in Younger At-Risk and Immunocompromised Adults
Arexvy is currently approved for active immunization for the prevention of LRTD caused by RSV in individuals 60 years of age and older, and those 50 to 59 years of age who are at increased risk for ...